(RTTNews) - Heska Corp. (HSKA) has agreed to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics. Headquartered in Boulder, Colorado, LightDeck has developed a scalable platform for rapid and accurate point of care diagnostics.
Kevin Wilson, Heska's CEO and President, said: "LightDeck was central in developing Heska's leading immunodiagnostic platform, Element i+, including its current menu of Total T4, cTSH, Cortisol, and Progesterone. We expect to drive gross margin improvement with new manufacturing capabilities and scaling across the business."
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
